ZA932061B - Halichondrins - Google Patents

Halichondrins

Info

Publication number
ZA932061B
ZA932061B ZA932061A ZA932061A ZA932061B ZA 932061 B ZA932061 B ZA 932061B ZA 932061 A ZA932061 A ZA 932061A ZA 932061 A ZA932061 A ZA 932061A ZA 932061 B ZA932061 B ZA 932061B
Authority
ZA
South Africa
Prior art keywords
chem
formula
halichondrins
lissodendyx
isolatable
Prior art date
Application number
ZA932061A
Other languages
English (en)
Inventor
Dolors G Gravalos
Robin J Lake
John W Blunt
Murray H G Munro
Marc Stephane Philibe Litaudon
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of ZA932061B publication Critical patent/ZA932061B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Dental Preparations (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA932061A 1992-03-23 1993-03-23 Halichondrins ZA932061B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929206244A GB9206244D0 (en) 1992-03-23 1992-03-23 Cytotoxic compound from a marine sponge

Publications (1)

Publication Number Publication Date
ZA932061B true ZA932061B (en) 1993-10-19

Family

ID=10712627

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA932061A ZA932061B (en) 1992-03-23 1993-03-23 Halichondrins

Country Status (12)

Country Link
US (1) US5786492A (es)
EP (1) EP0572109B1 (es)
JP (1) JP3168098B2 (es)
AT (1) ATE184009T1 (es)
AU (1) AU671818B2 (es)
CA (1) CA2092108A1 (es)
DE (1) DE69326192T2 (es)
DK (1) DK0572109T3 (es)
ES (1) ES2138993T3 (es)
GB (1) GB9206244D0 (es)
GR (1) GR3031981T3 (es)
ZA (1) ZA932061B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338865A (en) * 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
HU227912B1 (en) * 1998-06-17 2012-05-29 Eisai R & D Man Co Halichondrin analogs and methods of their use and preparation
PL2522663T3 (pl) 2004-06-03 2015-08-31 Eisai R&D Man Co Ltd Produkty pośrednie do otrzymywania halichondryny B
CN108948039B (zh) 2007-10-03 2021-12-31 卫材R&D管理有限公司 用于合成软海绵素b类似物的中间体和方法
CN105801599A (zh) 2008-04-04 2016-07-27 卫材R&D管理有限公司 软海绵素b类似物
JP2011528361A (ja) * 2008-07-15 2011-11-17 ビーエーエスエフ、カタリスツ、エルエルシー 二酸化塩素の投与のための方法、システムおよび機器
CN102803254B (zh) 2010-01-26 2016-09-14 卫材R&D管理有限公司 用于软海绵素b类似物合成的呋喃并[3,2-b]吡喃衍生物
CN105683198B (zh) 2013-11-04 2019-03-12 卫材R&D管理有限公司 软海绵素b的类似物合成中有用的大环化反应和中间体
HUE043088T2 (hu) 2013-12-06 2019-08-28 Eisai R&D Man Co Ltd Halikondrin B analógok szintézisében alkalmazható eljárások
EP3160970A4 (en) 2014-06-30 2017-12-27 President and Fellows of Harvard College Synthesis of halichondrin analogs and uses thereof
WO2016176560A1 (en) 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
RU2020141025A (ru) 2015-05-07 2020-12-28 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Реакции макроциклизации и промежуточные соединения и другие фрагменты, полезные в синтезе макролидов галихондринов
US10676481B2 (en) 2016-02-12 2020-06-09 Eisai R&D Management Co., Ltd. Intermediates in the synthesis of eribulin and related methods of synthesis
SG11201811671XA (en) 2016-06-30 2019-01-30 Eisai R&D Man Co Ltd Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
KR102836514B1 (ko) 2017-04-05 2025-07-22 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 마크로시클릭 화합물 및 그의 용도
US11332480B2 (en) 2017-04-27 2022-05-17 Pharma Mar, S.A. Antitumoral compounds
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
HUE061306T2 (hu) 2017-07-06 2023-06-28 Harvard College Halikondrinok szintézise
ES2974243T3 (es) 2017-11-15 2024-06-26 Harvard College Compuestos macrocíclicos y usos de los mismos
EP3713565A1 (en) 2017-11-20 2020-09-30 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of neoplastic diseases
KR20250057138A (ko) 2018-01-03 2025-04-28 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 마크롤리드 및 그의 유사체의 합성에 유용한 프린스 반응 및 화합물

Also Published As

Publication number Publication date
JPH06122687A (ja) 1994-05-06
EP0572109A1 (en) 1993-12-01
CA2092108A1 (en) 1993-09-24
AU671818B2 (en) 1996-09-12
ATE184009T1 (de) 1999-09-15
GB9206244D0 (en) 1992-05-06
DE69326192D1 (de) 1999-10-07
JP3168098B2 (ja) 2001-05-21
US5786492A (en) 1998-07-28
EP0572109B1 (en) 1999-09-01
AU3543393A (en) 1993-09-30
DK0572109T3 (da) 2000-03-27
GR3031981T3 (en) 2000-03-31
ES2138993T3 (es) 2000-02-01
DE69326192T2 (de) 2000-05-04

Similar Documents

Publication Publication Date Title
AU671818B2 (en) Halichondrins
IL89921A (en) 1,3-dioxolane derivatives and pharmaceutical compositions containing the same
AU5162796A (en) Novel peptide derivatives
TW269678B (es)
IL119118A0 (en) 9-Ú(Haloacyl) amido¾-7- (substituted)-6- demethyl-6-deoxytetracycline intermediates
AU4419193A (en) Synthesis of 1,4,7-triazacyclononane derivatives
IL96882A0 (en) Uracil derivatives and pesticides containing the same as active ingredient
HUT67742A (en) Phosphono-oxymethyl-ethers of taxane derivatives
CY2543B1 (en) 9-Ä(Substituted glycyl)amidoÜ-6-(substituted)-5-hydroxy-6-deoxytetracyclines
AU644051B2 (en) Piperidine derivatives
AU658296B2 (en) 7 beta-substituted-4-aza-5 alpha-cholestan-3-ones as 5 alpha-reductase inhibitors
GR3031521T3 (en) Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an anti-depressant drug.
TW257750B (es)
HUT71398A (en) Derivatives of dolastatin
HUP9600498A2 (en) Antimigrane 1,2,5-thiadiazole derivatives of 1-indolylalkyl-4-pyridinyl and -4-pyrimidinylpiperazines and pharmaceutical compositions containing the same
JPS6419066A (en) Dihydropyridineamides
AU5491194A (en) Cytotoxic and antiviral compound
PH30111A (en) Thiomarinol compounds
AU1174588A (en) Anticonvulsant agents
TW218011B (es)
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
EP0371762A3 (en) New platelet activating factor antagonists, named "the phomactins", their preparation and use
IL109958A0 (en) 14-Substituted marcfortines and derivatives useful as antiparasitic agents
NZ236734A (en) Alisamycin, pharmaceutical compositions and actinomycete culture (dsm 5559)
HUT50281A (en) Process for production of antihipertensive combinated compositions